US Brand Name
- Vonjo
Descriptions
Pacritinib is used to treat intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. Myelofibrosis is a life-threatening bone marrow problem which is manifested by the following symptoms: enlarged spleen (splenomegaly), severe itching, fever, night sweats, weight loss, bone pain, or unusual tiredness or weakness.
Pacritinib is a kinase inhibitor that works on the immune system.
This medicine is available only with your doctor’s prescription.
This product is available in the following dosage forms:
- Capsule
